These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17911443)

  • 1. Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of action.
    Lytton SD; Denton CP; Nutzenberger AM
    Ann N Y Acad Sci; 2007 Sep; 1110():285-96. PubMed ID: 17911443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression.
    Pankewycz O; Leca N; Kohli R; Wallace PK; Said M; Feng L; Alnimri M; Patel S; Laftavi MR
    Transplant Proc; 2011 Mar; 43(2):462-5. PubMed ID: 21440734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term immunoregulatory effects of therapy with corticosteroids and anti-thymocyte globulin.
    Schatz DA; Riley WJ; Silverstein JH; Barrett DJ
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):269-87. PubMed ID: 2695566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.
    LaCorcia G; Swistak M; Lawendowski C; Duan S; Weeden T; Nahill S; Williams JM; Dzuris JL
    Transplantation; 2009 Apr; 87(7):966-74. PubMed ID: 19352114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
    Liossis SN; Sfikakis PP
    Clin Immunol; 2008 Jun; 127(3):280-5. PubMed ID: 18337174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
    Jaeckel E; Mpofu N; Saal N; Manns MP
    Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model.
    Kaplan J; Woodworth L; Smith K; Coco J; Vitsky A; McPherson J
    Lupus; 2008 Sep; 17(9):822-31. PubMed ID: 18755864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of regulatory T-cells in autoimmunity.
    Mellanby RJ; Thomas DC; Lamb J
    Clin Sci (Lond); 2009 Apr; 116(8):639-49. PubMed ID: 19275768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of autoimmune disease with T cell subset specific antibodies.
    Sriram S; Ranges GE
    Concepts Immunopathol; 1987; 4():275-86. PubMed ID: 3297338
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer.
    Fietta AM; Morosini M; Passadore I; Cascina A; Draghi P; Dore R; Rossi S; Pozzi E; Meloni F
    Hum Immunol; 2009 Jul; 70(7):477-86. PubMed ID: 19332094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases.
    Bach MA; Bach JF
    Clin Exp Immunol; 1981 Sep; 45(3):449-56. PubMed ID: 6461443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.